Aeluma (ALMU) Q1 2027 earnings review
Aeluma buys wafer equipment, but commercial deals remain unsigned
Aeluma, a maker of optical chips for data centers and defense, is spending heavily to build commercial prototypes while its government contract revenue shrinks. First-quarter revenue fell 59% from a year ago to $0.6 million, matching the quarterly run-rate implied by management's full-year booked government contract outlook. By our math, research spending quadrupled to $2.5 million as the expanded engineering team worked on high-speed lasers and detectors, pushing the net loss to $3.8 million.
| Revenue | $0.57M -59% from a year ago |
|---|---|
| Net loss per share | -$0.19 -$0.09 a year ago |
| Cash and equivalents | $53.9M $56.0M last quarter |
| CHIPS funding outlook | Unchanged up to $30M still in diligence |
⚖️ Verdict: ⚪ Neutral
The story is unchanged because Aeluma signed its wafer-tool purchase agreement with Aixtron as planned, but still has not signed a single commercial customer contract. One caution: the company now links its high-volume customer discussions to the 2028 through 2032 data center buildout, and the Up to $30 million federal CHIPS award remains stuck in negotiations.
The question now is whether data center talks turn into paid development contracts before rival chipmakers solve the industry's supply shortage with their own larger wafers. Either customers sign upfront engineering deals in coming quarters to validate Aeluma's silicon-based process, or the company burns through its cash pile and issues more stock without commercial proof. A signed, dollar-quantified commercial engineering agreement by the third quarter will settle it.
🐂 Bull Case
Aeluma Signed Its Aixtron Reactor Purchase Agreement
Aeluma makes optical semiconductors on large silicon and gallium arsenide wafers rather than small, expensive indium phosphide crystals. To move beyond lab prototypes, the company signed a purchase agreement with equipment maker Aixtron for a 200-millimeter MOCVD system, a machine that deposits thin crystal layers onto wafers. Management said the tool will "expand manufacturing capacity and accelerate development for non-indium-phosphide photonics" alongside partner Sumitomo Chemical Advanced Technologies.
Signing the equipment contract turns last quarter's spending plan into a committed expansion after the company more than doubled its staff to over 30 employees last year. Capital spending was only $252 thousand this quarter, so by our math about $10.7 million of the full-year $10 million to $12 million equipment plan still lies ahead.
What to watch: equipment purchases on the cash flow statement over the next three quarters. A step-up toward the $10 million to $12 million full-year target will show when the new Aixtron machine arrives and starts qualification.
Cash Burn Stayed Contained Before Reactor Payments
Aeluma ended the quarter with $53.9 million in cash and no debt after raising $43.5 million from stock sales last fiscal year. The company used $1.75 million of cash in operations and $252 thousand for equipment, a total cash outflow of $2.0 million compared with $1.03 million a year ago.
That $2.0 million quarterly outflow leaves a large cushion while the larger engineering team develops optical chips for data centers. Interest earned on the cash pile brought in $492 thousand this quarter, up from $115 thousand a year ago, which covered nearly afifth of the quarter's research bill.
What to watch: quarterly operating and equipment cash outflow in the second-quarter filing. Staying near $2 million before reactor deposits hit would preserve the cash buffer for commercial qualification.
🐻 Bear Case
Customer Talks Still Have Produced No Signed Deals
Chief executive Jonathan Klamkin said Aeluma continues to expand customer discussions, including "negotiations on potential development investments and potentially large-volume product opportunities" for data center optical links. Management wants commercial customers to pay for non-recurring engineering (NRE), which is upfront customer funding to customize a chip design, to replace shrinking government contracts.
Yet the company still did not announce a single signed commercial engineering contract or customer qualification this quarter. Instead, the release said several customer initiatives aim "to support the 2028 through 2032 AI infrastructure buildout", and it dropped last quarter's count of active customer discussions. Pushing volume demand out to 2028 through 2032 means commercial product revenue remains years away while the company burns cash today.
What to watch: a press release or filing announcing a signed, dollar-quantified commercial engineering contract by the third quarter. Another quarter of unquantified talks would show that data center customers are still not committing funds.
Research Spending Quadrupled While Government Revenue Halved
Aeluma is deliberately winding down early-stage government research work to focus its engineers on commercial data center chips. Revenue fell 59.0% from a year ago to $568 thousand, and the release noted that sales still came primarily from research and development contracts. At the same time, internal research spending jumped as the company built prototypes with supply chain partners.
- Research and development expense: $2.53 million by our math, up 316.7% from $606 thousand a year ago
- Research and development share of revenue: up 400.8 percentage points from a year ago to 444.5%
- Gross margin: 40.3%, down 9.1 percentage points from 49.4% a year ago but up from 25.6% last quarter
- Operating loss: $4.25 million, compared with $1.61 million a year ago
Because revenue shrank while engineering payroll and wafer costs rose, the net loss more than doubled to $3.76 million. By our math, the $2.3 million full-year booked government contract outlook leaves $1.73 million for the rest of the year, or a 43.7% drop from a year ago unless new deals sign.
What to watch: quarterly revenue and research expense in the second-quarter report. Rising research costs without new commercial contract revenue will widen the operating loss further.
Share Count Rose 19% as CHIPS Talks Continue
Aeluma funds its operations and employee pay with stock. Weighted average common shares rose 19.4% from a year ago and 3.6% from last quarter to 19.27 million, following last quarter's at-the-market stock sales and ongoing option exercises. Stock-based compensation reached $1.38 million this quarter, or 28.6% of total operating expenses, which management excludes from its preferred loss measures.
In addition, the company remains in negotiations with the U.S. Department of Commerce CHIPS R&D Office for up to $30 million in proposed funding. Because that government award is structured as an equity investment rather than a grant, closing the deal and using the remaining $29.3 million stock-sale program will dilute existing shareholders further.
What to watch: the definitive CHIPS agreement terms and weighted average share count next quarter. The filing will show how many new shares Aeluma must issue to collect the federal funds.
Risks this quarter didn't answer
Two standing operational and competitive risks received no new data in the first-quarter earnings release.
- Rival 6-inch indium phosphide capacity: incumbent laser makers are expanding traditional wafer lines for 2027 and 2028; customer qualification wins will show whether Aeluma's silicon-based alternative arrives in time.
- Reactor installation and foundry qualification: Aeluma signed the Aixtron purchase order and works with Sumitomo to "ready technology in a production environment", but gave no delivery or qualification dates; future filings must provide the schedule.
👓 Other Themes
AI Data Center Supply Chains Remain Tight
"The current U.S. AI infrastructure buildout continues to progress and is expected to reach an aggregate investment of $10.3 trillion in 2032," Klamkin said. He noted that industry supply chains for traditional indium phosphide wafers and fabrication plants are constrained, which creates the opening Aeluma hopes to fill by making optical chips on standard silicon and gallium arsenide wafers.
💲 Other KPIs
Accounts receivable — money owed by customers for contract work already billed — rose 48.2% from last quarter to $504 thousand, even as revenue dipped 2.4% to $568 thousand. Receivables had fallen from $1.06 million in the third quarter to $340 thousand in the fourth quarter, and this quarter's rebound reduced operating cash flow by $164 thousand.
Overhead and administrative spending fell 13.1% from last quarter's $2.25 million peak, though it remains up 15.8% from $1.69 million a year ago after the company doubled its staff. At 343.7% of revenue, administrative overhead alone is still more than three times the company's quarterly sales.
🔮 Guidance
Unchanged. Aeluma remains in diligence and definitive agreement negotiations with the U.S. Department of Commerce for up to $30 million in proposed funding to develop photonics for AI and advanced computing. Management first announced the letter of intent last quarter, and the release gave no closing date or milestone schedule.
❓ Key Questions
Why did commercial volume framing shift to 2028 through 2032?
The release tied high-volume customer discussions to the 2028 through 2032 AI buildout and still announced no signed commercial engineering contracts. Investors need to know if any customer will pay for development work in fiscal 2027.
How many active customer discussions and proposals are in the pipeline?
Management previously cited upwards of 30 customer engagements and several multi-million-dollar engineering agreements in negotiation, but the first-quarter release dropped all specific counts. Without pipeline numbers, readers cannot tell if talks are advancing or stalling.
When will the Aixtron reactor arrive and trigger the $10–12M capex?
Aeluma signed the Aixtron purchase agreement, but first-quarter equipment spending was only $252 thousand. Management needs to state when the $10.7 million of remaining planned equipment payments will leave the bank account and when the tool will qualify.
What equity price and milestones govern the $30M CHIPS funding?
The proposed $30 million federal award remains in diligence and is structured as an equity issuance. Shareholders need to know the share pricing formula, governance rules, and technical milestones attached to the cash.